Comprehensive assessment of levodopa-carbidopa intestinal gel for Turkish advanced Parkinson’s disease patients

BACKGROUND/AIM: Levodopa-carbidopa intestinal gel (LCIG) is an effective treatment modality in the management of advanced Parkinson’s disease (PD) despite frequent adverse events and different rates of dropouts. Efficacy and safety data regarding Turkish patients on LCIG are limited. This study aims...

Descripción completa

Detalles Bibliográficos
Autores principales: SÜCÜLLÜ KARADAĞ, Yeşim, SALTOĞLU, Tuğçe, ERDOĞAN KÜÇÜKDAĞLI, Fadime, ÖZTÜRK, Ömer, KÖSEOĞLU, Tankut, ALTIPARMAK, Emin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991872/
https://www.ncbi.nlm.nih.gov/pubmed/32718129
http://dx.doi.org/10.3906/sag-2005-96

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991872/
https://www.ncbi.nlm.nih.gov/pubmed/32718129
http://dx.doi.org/10.3906/sag-2005-96

Ejemplares similares